NEWSROOM
Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital leads oversubscribed $75 million Series C in Adcendo ApS to Advance its First- and Best-in-class Clinical ADC Pipeline in Oncology
Proceeds from the financing will support the advancement of three first- and best-in-class ADC[1] programs through upcoming key clinical milestones While oncology continues to face substantial and largely unmet needs, Jeito will leverage its expertise to accelerate...
Download our White Paper
We are pleased to share with you our White Paper, which offers a deep dive into the evolving biopharma landscape and highlights the key trends shaping its future.
Find all our press releases
Jeito Capital hits record $1.2 billion (€1 billion) close for Jeito II Fund to drive breakthrough therapeutic innovation for patients
This record closing is the largest raise ever achieved by a fully independent European fund...
Jeito Capital appoints Samit Hirawat, M.D., as Strategic Medical Advisor to strengthen Jeito’s leadership in driving innovations for patient benefit
Samit Hirawat, M.D., brings over 25 years of senior leadership and clinical development experience...
Jeito Capital Makes Significant Investment in the Second Closing of Alveus Therapeutics’ Oversubscribed Series A, Bringing Total Financing to $197 Million
Proceeds from the financing will advance the Phase 2 clinical development of Alveus’ lead program...
Jeito Capital promotes Ksenija Pavletic to General Partner
Paris, France, October 15th, 2025 – Jeito Capital (“Jeito”), a leading global independent private...
Jeito Capital announces significant participation in oversubscribed $213M Series D financing for Odyssey Therapeutics to advance clinical pipeline addressing autoimmune diseases with high unmet needs
Investment will support Odyssey’s portfolio of clinical and preclinical medicines designed to...
Jeito Capital appoints Pascal Touchon as Operating Partner
Pascal Touchon will reinforce Jeito's expertise by bringing over 35 years of global experience in...
Face to face
Meet Jeito
12-15
January
All day long
JPM Healthcare Conference 2026
Jeito will be present at the 44th JPM Healthcare Conference 2026, renowned as the largest and most influential healthcare investment symposium, attracting global industry leaders, Biotech companies, and members of the investment community, in San Francisco.